Reviews Eprosartan Mesylate Hydrochlorothiazide Tablets


No reviews yet.

Teveten HCT Drug Description
TEVETEN® HCT
(eprosartan mesylate/hydrochlorothiazide) 600/12.5 mg and 600/25 mg Tablets

USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, drugs that
act directly on the renin-angiotensin system can cause injury and even death
to the developing fetus. When pregnancy is detected, TEVETEN® HCT
Tablets should be discontinued as soon as possible. See WARNINGS:
Fetal/Neonatal Morbidity and Mortality.

DRUG DESCRIPTION



What are the possible side effects of eprosartan (Teveten)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
In rare cases, eprosartan can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have muscle pain, tenderness, or weakness especially if you also have fever, nausea or vomiting, and dark colored urine.
Call your doctor at once if you have any of these other...
Read All Potential Side Effects for Teveten HCT »




TEVETEN® HCT 600/12.5 and TEVETEN® HCT 600/25 (eprosartan mesylate-hydrochlorothiazide)
combine an angiotensin II receptor (AT1 subtype) antagonist and a
diuretic, hydrochlorothiazide. TEVETEN® (eprosartan mesylate) is a non-biphenyl
non-tetrazole angiotensin II receptor (AT1) antagonist. A selective
non-peptide molecule, TEVETEN® is chemically described as the monomethanesulfonate
of (E)-2-butyl-1-(p-carboxybenzyl)-α-2-thienylmethylimidazole-5-acrylic
acid. Its empirical formula is C23H24N2O4S•CH4O3S
and molecular weight is 520.625. Its structural formula is:








Eprosartan mesylate is a white to off-white free-flowing crystalline powder
that is insoluble in water, freely soluble in ethanol, and melts between 248°C
and 250°C. Hydrochlorothiazide is 6-chloro-3,4-dihydro-2 H 1,2,4-benzothiadiazine-7-sulfonamide
1,1-dioxide. Its empirical formula is C7H8CIN3O4S2
and its structural formula is:








Hydrochlorothiazide is a white, or practically white, crystalline powder with
a molecular weight of 297.74, which is slightly soluble in water, but freely
soluble in sodium hydroxide solution. TEVETEN® HCT is available for oral
administration in film-coated, non-scored, capsule-shaped tablet combinations
of eprosartan mesylate and hydrochlorothiazide. TEVETEN® HCT 600/12.5 contains
735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and 12.5 mg
hydrochlorothiazide in a butterscotch-colored tablet. TEVETEN® HCT 600/25
contains 735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and
25 mg hydrochlorothiazide in a brick-red tablet. Inactive ingredients of both
tablets: microcrystalline cellulose, lactose monohydrate, pregelatinized starch,
crospovidone, magnesium stearate, and purified water. Ingredients of the OPADRY®
85F27320 butterscotch film coating: polyethylene glycol 3350, talc, polyvinyl
alcohol, titanium dioxide, iron oxide black, and iron oxide yellow. Ingredients
of the OPADRY® II 85F24297 pink film coating: polyethylene glycol 3350,
titanium dioxide, talc, polyvinyl alcohol, iron oxide red, and iron oxide yellow.Last reviewed on RxList: 7/16/2008




Teveten HCT Drug Description
TEVETEN® HCT
(eprosartan mesylate/hydrochlorothiazide) 600/12.5 mg and 600/25 mg Tablets

USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, drugs that
act directly on the renin-angiotensin system can cause injury and even death
to the developing fetus. When pregnancy is detected, TEVETEN® HCT
Tablets should be discontinued as soon as possible. See WARNINGS:
Fetal/Neonatal Morbidity and Mortality.

DRUG DESCRIPTION



What are the possible side effects of eprosartan (Teveten)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
In rare cases, eprosartan can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have muscle pain, tenderness, or weakness especially if you also have fever, nausea or vomiting, and dark colored urine.
Call your doctor at once if you have any of these other...
Read All Potential Side Effects for Teveten HCT »




TEVETEN® HCT 600/12.5 and TEVETEN® HCT 600/25 (eprosartan mesylate-hydrochlorothiazide)
combine an angiotensin II receptor (AT1 subtype) antagonist and a
diuretic, hydrochlorothiazide. TEVETEN® (eprosartan mesylate) is a non-biphenyl
non-tetrazole angiotensin II receptor (AT1) antagonist. A selective
non-peptide molecule, TEVETEN® is chemically described as the monomethanesulfonate
of (E)-2-butyl-1-(p-carboxybenzyl)-α-2-thienylmethylimidazole-5-acrylic
acid. Its empirical formula is C23H24N2O4S•CH4O3S
and molecular weight is 520.625. Its structural formula is:








Eprosartan mesylate is a white to off-white free-flowing crystalline powder
that is insoluble in water, freely soluble in ethanol, and melts between 248°C
and 250°C. Hydrochlorothiazide is 6-chloro-3,4-dihydro-2 H 1,2,4-benzothiadiazine-7-sulfonamide
1,1-dioxide. Its empirical formula is C7H8CIN3O4S2
and its structural formula is:








Hydrochlorothiazide is a white, or practically white, crystalline powder with
a molecular weight of 297.74, which is slightly soluble in water, but freely
soluble in sodium hydroxide solution. TEVETEN® HCT is available for oral
administration in film-coated, non-scored, capsule-shaped tablet combinations
of eprosartan mesylate and hydrochlorothiazide. TEVETEN® HCT 600/12.5 contains
735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and 12.5 mg
hydrochlorothiazide in a butterscotch-colored tablet. TEVETEN® HCT 600/25
contains 735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and
25 mg hydrochlorothiazide in a brick-red tablet. Inactive ingredients of both
tablets: microcrystalline cellulose, lactose monohydrate, pregelatinized starch,
crospovidone, magnesium stearate, and purified water. Ingredients of the OPADRY®
85F27320 butterscotch film coating: polyethylene glycol 3350, talc, polyvinyl
alcohol, titanium dioxide, iron oxide black, and iron oxide yellow. Ingredients
of the OPADRY® II 85F24297 pink film coating: polyethylene glycol 3350,
titanium dioxide, talc, polyvinyl alcohol, iron oxide red, and iron oxide yellow.Last reviewed on RxList: 7/16/2008




Teveten HCT Drug Description
TEVETEN® HCT
(eprosartan mesylate/hydrochlorothiazide) 600/12.5 mg and 600/25 mg Tablets

USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, drugs that
act directly on the renin-angiotensin system can cause injury and even death
to the developing fetus. When pregnancy is detected, TEVETEN® HCT
Tablets should be discontinued as soon as possible. See WARNINGS:
Fetal/Neonatal Morbidity and Mortality.

DRUG DESCRIPTION



What are the possible side effects of eprosartan (Teveten)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
In rare cases, eprosartan can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have muscle pain, tenderness, or weakness especially if you also have fever, nausea or vomiting, and dark colored urine.
Call your doctor at once if you have any of these other...
Read All Potential Side Effects for Teveten HCT »




TEVETEN® HCT 600/12.5 and TEVETEN® HCT 600/25 (eprosartan mesylate-hydrochlorothiazide)
combine an angiotensin II receptor (AT1 subtype) antagonist and a
diuretic, hydrochlorothiazide. TEVETEN® (eprosartan mesylate) is a non-biphenyl
non-tetrazole angiotensin II receptor (AT1) antagonist. A selective
non-peptide molecule, TEVETEN® is chemically described as the monomethanesulfonate
of (E)-2-butyl-1-(p-carboxybenzyl)-α-2-thienylmethylimidazole-5-acrylic
acid. Its empirical formula is C23H24N2O4S•CH4O3S
and molecular weight is 520.625. Its structural formula is:








Eprosartan mesylate is a white to off-white free-flowing crystalline powder
that is insoluble in water, freely soluble in ethanol, and melts between 248°C
and 250°C. Hydrochlorothiazide is 6-chloro-3,4-dihydro-2 H 1,2,4-benzothiadiazine-7-sulfonamide
1,1-dioxide. Its empirical formula is C7H8CIN3O4S2
and its structural formula is:








Hydrochlorothiazide is a white, or practically white, crystalline powder with
a molecular weight of 297.74, which is slightly soluble in water, but freely
soluble in sodium hydroxide solution. TEVETEN® HCT is available for oral
administration in film-coated, non-scored, capsule-shaped tablet combinations
of eprosartan mesylate and hydrochlorothiazide. TEVETEN® HCT 600/12.5 contains
735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and 12.5 mg
hydrochlorothiazide in a butterscotch-colored tablet. TEVETEN® HCT 600/25
contains 735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and
25 mg hydrochlorothiazide in a brick-red tablet. Inactive ingredients of both
tablets: microcrystalline cellulose, lactose monohydrate, pregelatinized starch,
crospovidone, magnesium stearate, and purified water. Ingredients of the OPADRY®
85F27320 butterscotch film coating: polyethylene glycol 3350, talc, polyvinyl
alcohol, titanium dioxide, iron oxide black, and iron oxide yellow. Ingredients
of the OPADRY® II 85F24297 pink film coating: polyethylene glycol 3350,
titanium dioxide, talc, polyvinyl alcohol, iron oxide red, and iron oxide yellow.Last reviewed on RxList: 7/16/2008




Teveten HCT Drug Description
TEVETEN® HCT
(eprosartan mesylate/hydrochlorothiazide) 600/12.5 mg and 600/25 mg Tablets

USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, drugs that
act directly on the renin-angiotensin system can cause injury and even death
to the developing fetus. When pregnancy is detected, TEVETEN® HCT
Tablets should be discontinued as soon as possible. See WARNINGS:
Fetal/Neonatal Morbidity and Mortality.

DRUG DESCRIPTION



What are the possible side effects of eprosartan (Teveten)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
In rare cases, eprosartan can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have muscle pain, tenderness, or weakness especially if you also have fever, nausea or vomiting, and dark colored urine.
Call your doctor at once if you have any of these other...
Read All Potential Side Effects for Teveten HCT »




TEVETEN® HCT 600/12.5 and TEVETEN® HCT 600/25 (eprosartan mesylate-hydrochlorothiazide)
combine an angiotensin II receptor (AT1 subtype) antagonist and a
diuretic, hydrochlorothiazide. TEVETEN® (eprosartan mesylate) is a non-biphenyl
non-tetrazole angiotensin II receptor (AT1) antagonist. A selective
non-peptide molecule, TEVETEN® is chemically described as the monomethanesulfonate
of (E)-2-butyl-1-(p-carboxybenzyl)-α-2-thienylmethylimidazole-5-acrylic
acid. Its empirical formula is C23H24N2O4S•CH4O3S
and molecular weight is 520.625. Its structural formula is:








Eprosartan mesylate is a white to off-white free-flowing crystalline powder
that is insoluble in water, freely soluble in ethanol, and melts between 248°C
and 250°C. Hydrochlorothiazide is 6-chloro-3,4-dihydro-2 H 1,2,4-benzothiadiazine-7-sulfonamide
1,1-dioxide. Its empirical formula is C7H8CIN3O4S2
and its structural formula is:








Hydrochlorothiazide is a white, or practically white, crystalline powder with
a molecular weight of 297.74, which is slightly soluble in water, but freely
soluble in sodium hydroxide solution. TEVETEN® HCT is available for oral
administration in film-coated, non-scored, capsule-shaped tablet combinations
of eprosartan mesylate and hydrochlorothiazide. TEVETEN® HCT 600/12.5 contains
735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and 12.5 mg
hydrochlorothiazide in a butterscotch-colored tablet. TEVETEN® HCT 600/25
contains 735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and
25 mg hydrochlorothiazide in a brick-red tablet. Inactive ingredients of both
tablets: microcrystalline cellulose, lactose monohydrate, pregelatinized starch,
crospovidone, magnesium stearate, and purified water. Ingredients of the OPADRY®
85F27320 butterscotch film coating: polyethylene glycol 3350, talc, polyvinyl
alcohol, titanium dioxide, iron oxide black, and iron oxide yellow. Ingredients
of the OPADRY® II 85F24297 pink film coating: polyethylene glycol 3350,
titanium dioxide, talc, polyvinyl alcohol, iron oxide red, and iron oxide yellow.Last reviewed on RxList: 7/16/2008




Teveten HCT Drug Description
TEVETEN® HCT
(eprosartan mesylate/hydrochlorothiazide) 600/12.5 mg and 600/25 mg Tablets

USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, drugs that
act directly on the renin-angiotensin system can cause injury and even death
to the developing fetus. When pregnancy is detected, TEVETEN® HCT
Tablets should be discontinued as soon as possible. See WARNINGS:
Fetal/Neonatal Morbidity and Mortality.

DRUG DESCRIPTION



What are the possible side effects of eprosartan (Teveten)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
In rare cases, eprosartan can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have muscle pain, tenderness, or weakness especially if you also have fever, nausea or vomiting, and dark colored urine.
Call your doctor at once if you have any of these other...
Read All Potential Side Effects for Teveten HCT »




TEVETEN® HCT 600/12.5 and TEVETEN® HCT 600/25 (eprosartan mesylate-hydrochlorothiazide)
combine an angiotensin II receptor (AT1 subtype) antagonist and a
diuretic, hydrochlorothiazide. TEVETEN® (eprosartan mesylate) is a non-biphenyl
non-tetrazole angiotensin II receptor (AT1) antagonist. A selective
non-peptide molecule, TEVETEN® is chemically described as the monomethanesulfonate
of (E)-2-butyl-1-(p-carboxybenzyl)-α-2-thienylmethylimidazole-5-acrylic
acid. Its empirical formula is C23H24N2O4S•CH4O3S
and molecular weight is 520.625. Its structural formula is:








Eprosartan mesylate is a white to off-white free-flowing crystalline powder
that is insoluble in water, freely soluble in ethanol, and melts between 248°C
and 250°C. Hydrochlorothiazide is 6-chloro-3,4-dihydro-2 H 1,2,4-benzothiadiazine-7-sulfonamide
1,1-dioxide. Its empirical formula is C7H8CIN3O4S2
and its structural formula is:








Hydrochlorothiazide is a white, or practically white, crystalline powder with
a molecular weight of 297.74, which is slightly soluble in water, but freely
soluble in sodium hydroxide solution. TEVETEN® HCT is available for oral
administration in film-coated, non-scored, capsule-shaped tablet combinations
of eprosartan mesylate and hydrochlorothiazide. TEVETEN® HCT 600/12.5 contains
735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and 12.5 mg
hydrochlorothiazide in a butterscotch-colored tablet. TEVETEN® HCT 600/25
contains 735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and
25 mg hydrochlorothiazide in a brick-red tablet. Inactive ingredients of both
tablets: microcrystalline cellulose, lactose monohydrate, pregelatinized starch,
crospovidone, magnesium stearate, and purified water. Ingredients of the OPADRY®
85F27320 butterscotch film coating: polyethylene glycol 3350, talc, polyvinyl
alcohol, titanium dioxide, iron oxide black, and iron oxide yellow. Ingredients
of the OPADRY® II 85F24297 pink film coating: polyethylene glycol 3350,
titanium dioxide, talc, polyvinyl alcohol, iron oxide red, and iron oxide yellow.Last reviewed on RxList: 7/16/2008





Other reviews about Eprosartan Mesylate Hydrochlorothiazide Tablets on web:

Eprosartan Mesylate, Hydrochlorothiazide Oral tablet To return to the main entry click here . What is this medicine? EPROSARTAN; HYDROCHLOROTHIAZIDE Eprosartan Mesylate, Hydrochlorothiazide Oral tablet: Information ...


Learn about the prescription medication Teveten HCT (Eprosartan Mesylate Hydrochlorothiazide Tablets), drug uses, dosage, side effects, drug interactions, warnings, reviews and ... Teveten HCT (Eprosartan Mesylate Hydrochlorothiazide Tablets) Drug ...


(Nos. 3015, 3020) TEVETEN テδづつョ HCT (eprosartan mesylate/hydrochlorothiazide) 600/12.5 mg and 600/25 mg Tablets PRESCRIBING INFORMATION DESCRIPTION TEVETEN テδづつョ HCT 600/12.5 mg and TEVETEN テδづつョ HCT ... TEVETENテδづつョ HCT (eprosartan mesylate/hydrochlorothiazide)


Eprosartan Mesylate, Hydrochlorothiazide Oral tablet Eprosartan; Hydrochlorothiazide, HCTZ


Learn about Teveten HCT (Eprosartan Mesylate Hydrochlorothiazide Tablets) - Side Effects, Drug Interactions, Pictures, Patient Information on RxList Teveten HCT (Eprosartan Mesylate Hydrochlorothiazide Tablets ...


Comprehensive and trusted information about Eprosartan mesylate and Hydrochlorothiazide - plus advice on ... The usual starting dose is one 600/12.5 tablet per day. If your blood ... Eprosartan mesylate and Hydrochlorothiazide patient advice ...


Eprosartan Mesylate, Hydrochlorothiazide Oral tablet What is this medicine? EPROSARTAN; HYDROCHLOROTHIAZIDE (ep roe SAR tan; hye droe klor oh THYE a zide) is a combination of a drug ... Memorial Health Care System: Drug Reference


Eprosartan Mesylate, Hydrochlorothiazide Oral tablet What is this medicine? EPROSARTAN; HYDROCHLOROTHIAZIDE (ep roe SAR tan; hye droe klor oh THYE a zide) is a combination of a drug ... United Health Services - Eprosartan; Hydrochlorothiazide, HCTZ


Tevetenテδづつョ HCT 600/12.5 contains 735.8 mg of eprosartan mesylate (equivalent to 600 mg eprosartan) and 12.5 mg hydrochlorothiazide in a butterscotch-colored tablet. Clinical:Teveten hct (eprosartan mesylate and hydrochlorothiazide ...


To return to the main entry click here. What is this medicine? ... Mentioned in. Eprosartan Mesylate, Hydrochlorothiazide Oral tablet Eprosartan Mesylate Oral tablet: Information from Answers.com





Featured Reviews

Reviews Erythromycin

Ilotycin Drug Description DRUG DESCRIPTION Ilotycin® (Erythromycin Ophthalmic Ointment, USP) belongs to the macrolide group of antibiotics. It is basic and readily forms a salt when combined with an acid. The base, as crystals or...
Read More  |  Review This
Reviews Melquin-3 Topical Solution

Melquin-3 Topical Solution Drug Description Melquin-3 Topical Solution (hydroquinone) 3% Topical Solution DRUG DESCRIPTION What are the possible side effects of hydroquinone topical? Get emergency medical help if you have any of...
Read More  |  Review This
Reviews Coagulation Factor IX Recombinant

Benefix Drug Description BeneFIX® [coagulation factor IX (recombinant)] DRUG DESCRIPTION What are the possible side effects of coagulation factor IX (Alphanine SD, Benefix, Mononine)? Get emergency medical help if you have...
Read More  |  Review This
Reviews Antabuse

Antabuse Drug Description ANTABUSE (disulfiram) Tablet WARNING Disulfiram should never be administered to a patient when he is in a state of alcohol intoxication, or without his full knowledge. The physician should instruct relatives...
Read More  |  Review This
Reviews Grifulvin V

Grifulvin V Drug Description Grifulvin V® (griseofulvin tablets) Microsize and (griseofulvin oral suspension) Microsize Tablets/Suspension DRUG DESCRIPTION What are the possible side effects of griseofulvin? Stop taking...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....